Skip to main content

Table 1 HLA-class I genotyping of TC RCC and healthy donor-2 and donor-3 PBMCs included in MLTC

From: miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction

 

HLA–A*

HLA–B*

HLA–C*

TC RCC

03:01 24:02

07:02 08:01

07:02 07:02

Donor-2

03:01 24:02

07:02 08:01

07:02 07:02

Donor-3

03:01 24:02

07:02 08:01

07:02 07:02